Literature DB >> 23504369

Technologies for investigating the physiological barriers to efficient lipid nanoparticle-siRNA delivery.

Bin Shi1, Marc Abrams.   

Abstract

Small interfering RNA (siRNA) therapeutics have advanced from bench to clinical trials in recent years, along with new tools developed to enable detection of siRNA delivered at the organ, cell, and subcellular levels. Preclinical models of siRNA delivery have benefitted from methodologies such as stem-loop quantitative polymerase chain reaction, histological in situ immunofluorescent staining, endosomal escape assay, and RNA-induced silencing complex loading assay. These technologies have accelerated the detection and optimization of siRNA platforms to overcome the challenges associated with delivering therapeutic oligonucleotides to the cytosol of specific target cells. This review focuses on the methodologies and their application in the biodistribution of siRNA delivered by lipid nanoparticles.

Entities:  

Keywords:  LNP; QWBA; RISC; biodistribution; delivery; endosomal escape; immunofluorescence staining; intravital imaging; lipid nanoparticle; siRNA; stem-loop PCR

Mesh:

Substances:

Year:  2013        PMID: 23504369      PMCID: PMC3715328          DOI: 10.1369/0022155413484152

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  137 in total

Review 1.  The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis.

Authors:  Michelle A Carmell; Zhenyu Xuan; Michael Q Zhang; Gregory J Hannon
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

Review 2.  Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics.

Authors:  Marian E Gindy; Anthony M Leone; James J Cunningham
Journal:  Expert Opin Drug Deliv       Date:  2012-02       Impact factor: 6.648

Review 3.  Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.

Authors:  Shyh-Dar Li; Leaf Huang
Journal:  Curr Opin Investig Drugs       Date:  2008-12

4.  Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery.

Authors:  Bin Shi; Ed Keough; Andrea Matter; Karen Leander; Stephanie Young; Ed Carlini; Alan B Sachs; Weikang Tao; Marc Abrams; Bonnie Howell; Laura Sepp-Lorenzino
Journal:  J Histochem Cytochem       Date:  2011-08       Impact factor: 2.479

5.  Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.

Authors:  James O McNamara; Eran R Andrechek; Yong Wang; Kristi D Viles; Rachel E Rempel; Eli Gilboa; Bruce A Sullenger; Paloma H Giangrande
Journal:  Nat Biotechnol       Date:  2006-06-25       Impact factor: 54.908

6.  Dicetyl phosphate-tetraethylenepentamine-based liposomes for systemic siRNA delivery.

Authors:  Tomohiro Asai; Saori Matsushita; Eriya Kenjo; Takuma Tsuzuku; Norihito Yonenaga; Hiroyuki Koide; Kentaro Hatanaka; Takehisa Dewa; Mamoru Nango; Noriyuki Maeda; Hiroshi Kikuchi; Naoto Oku
Journal:  Bioconjug Chem       Date:  2011-03-01       Impact factor: 4.774

7.  Effect of biological matrix and sample preparation on qPCR quantitation of siRNA drugs in animal tissues.

Authors:  Jessica Seitzer; Hangchun Zhang; Martin Koser; Yi Pei; Marc Abrams
Journal:  J Pharmacol Toxicol Methods       Date:  2010-09-25       Impact factor: 1.950

Review 8.  Cationic liposome-nucleic acid complexes for gene delivery and silencing: pathways and mechanisms for plasmid DNA and siRNA.

Authors:  Kai K Ewert; Alexandra Zidovska; Ayesha Ahmad; Nathan F Bouxsein; Heather M Evans; Christopher S McAllister; Charles E Samuel; Cyrus R Safinya
Journal:  Top Curr Chem       Date:  2010

9.  RNA interference by osmotic lysis of pinosomes: liposome-independent transfection of siRNAs into mammalian cells.

Authors:  Jens Gruber; Guido Boese; Thomas Tuschl; Mary Osborn; Klaus Weber
Journal:  Biotechniques       Date:  2004-07       Impact factor: 1.993

10.  A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion.

Authors:  Charles J Russell; Karen L Kantor; Theodore S Jardetzky; Robert A Lamb
Journal:  J Cell Biol       Date:  2003-10-27       Impact factor: 10.539

View more
  5 in total

1.  Three-dimensional localization of polymer nanoparticles in cells using ToF-SIMS.

Authors:  Daniel J Graham; John T Wilson; James J Lai; Patrick S Stayton; David G Castner
Journal:  Biointerphases       Date:  2015-06-03       Impact factor: 2.456

Review 2.  Cellular Delivery of RNA Nanoparticles.

Authors:  Lorena Parlea; Anu Puri; Wojciech Kasprzak; Eckart Bindewald; Paul Zakrevsky; Emily Satterwhite; Kenya Joseph; Kirill A Afonin; Bruce A Shapiro
Journal:  ACS Comb Sci       Date:  2016-08-26       Impact factor: 3.784

Review 3.  Current progress on aptamer-targeted oligonucleotide therapeutics.

Authors:  Justin P Dassie; Paloma H Giangrande
Journal:  Ther Deliv       Date:  2013-12

4.  Intratracheal Administration of siRNA Triggers mRNA Silencing in the Lung to Modulate T Cell Immune Response and Lung Inflammation.

Authors:  Bruce Ng; Tanesha Cash-Mason; Yi Wang; Jessica Seitzer; Julja Burchard; Duncan Brown; Vadim Dudkin; Joseph Davide; Vasant Jadhav; Laura Sepp-Lorenzino; Pedro J Cejas
Journal:  Mol Ther Nucleic Acids       Date:  2019-02-26

Review 5.  Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics.

Authors:  P Vervaeke; S E Borgos; N N Sanders; F Combes
Journal:  Adv Drug Deliv Rev       Date:  2022-03-26       Impact factor: 17.873

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.